- Home
- NISN vs CLDI Comparison
NISN vs CLDI Comparison
Compare NISN & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- CLDI
- Stock Information
- Founded
- NISN 2005
- CLDI 2014
- Country
- NISN China
- CLDI United States
- Employees
- NISN N/A
- CLDI N/A
- Industry
- NISN Metal Fabrications
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NISN Industrials
- CLDI Health Care
- Exchange
- NISN Nasdaq
- CLDI Nasdaq
- Market Cap
- NISN 19.4M
- CLDI 20.2M
- IPO Year
- NISN 2016
- CLDI N/A
- Fundamental
- Price
- NISN $3.48
- CLDI $1.60
- Analyst Decision
- NISN
- CLDI
- Analyst Count
- NISN 0
- CLDI 0
- Target Price
- NISN N/A
- CLDI N/A
- AVG Volume (30 Days)
- NISN 15.7K
- CLDI 484.3K
- Earning Date
- NISN 10-14-2025
- CLDI 11-11-2025
- Dividend Yield
- NISN N/A
- CLDI N/A
- EPS Growth
- NISN N/A
- CLDI N/A
- EPS
- NISN 1.43
- CLDI N/A
- Revenue
- NISN $340,219,546.00
- CLDI N/A
- Revenue This Year
- NISN N/A
- CLDI N/A
- Revenue Next Year
- NISN N/A
- CLDI N/A
- P/E Ratio
- NISN $15.49
- CLDI N/A
- Revenue Growth
- NISN 8.05
- CLDI N/A
- 52 Week Low
- NISN $3.22
- CLDI $1.51
- 52 Week High
- NISN $22.55
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- NISN 37.28
- CLDI 30.60
- Support Level
- NISN $3.49
- CLDI $1.51
- Resistance Level
- NISN $3.75
- CLDI $1.68
- Average True Range (ATR)
- NISN 0.19
- CLDI 0.10
- MACD
- NISN -0.01
- CLDI 0.14
- Stochastic Oscillator
- NISN 24.00
- CLDI 22.97
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.